Genome & Co

314130

Company Profile

  • Business description

    Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

  • Contact

    Innovalley A-801
    Pangyo-ro 253, Bundang-gu
    Gyeonggi-do
    Seongnam-si13486
    KOR

    T: +82 316280150

    http://www.genomecom.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    92

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,660.3022.500.26%
CAC 407,805.2425.520.33%
DAX 4024,127.39194.160.81%
Dow JONES (US)42,215.73117.030.28%
FTSE 1008,775.2058.750.67%
HKSE23,289.77283.61-1.20%
NASDAQ19,175.8774.930.39%
Nikkei 22537,965.10467.88-1.22%
NZX 50 Index12,418.89137.581.12%
S&P 5005,912.1723.620.40%
S&P/ASX 2008,434.7024.900.30%
SSE Composite Index3,347.4915.96-0.47%

Market Movers